METABOLISM OF SOYBEAN ISOFLAVONOIDS AND LIGNANS IN MAN

大豆异黄酮和木脂素在人体中的代谢

基本信息

  • 批准号:
    2008023
  • 负责人:
  • 金额:
    $ 13.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-09-30 至 1998-12-31
  • 项目状态:
    已结题

项目摘要

Soybeans have been found to contain both isoflavonoids and lignans. These diphenolic compounds have in numerous experiments in vitro with cell cultures and in animal experiments been shown to have antiproliferative properties with regard to many types of cancer and have been shown to stimulate differentiation of many leukemic cell lines. In addition they have many other biological effects making them strong candidates for a role as cancer protective agents. The aim of the present investigation is to continue to develop methodology for quantitative measurements of lignans and isoflavonoids in human biological fluids and food specimens using immunological and GC-MS techniques. Polyclonal and monoclonal antibodies will be produced for genistein, daidzein, equol and enterolactone. The main goal is to simplify the techniques making it possible to study larger populations. When these methods are ready it is intended to measure these compounds in already collected plasma samples of groups of young and old women consuming different types of habitual diets (lactovegetarians, omnivores) and two groups of women having been operated for early breast cancer. These samples are unique because we have complete dietary records and assay results for isoflavonoids and lignans in urine as well as for a great number of other steroid and peptide hormones in plasma, urine and feces (more than 50 components). Furthermore it is intended to continue studies on the antiproliferative effects and mechanism of action of phytoestrogens including mammalian lignans and their precursors, which have been synthesized by us, on malignant cell lines using modern techniques. We intend to study particularly human breast, prostate, endometrium and liver cancer cells. These studies will be carried out by adding the compounds alone to cell cultures or in combination or combined with various estrogens, testosterone, antiestrogens, compounds binding to the type II estrogen binding site and antiestrogen binding site, which all have been synthesized already. Simultaneously we measure various proteins like prostatic specific antigen or sex hormone binding globulin in the medium and use molecular biology techniques for clarifying mechanisms. We will also continue the synthesis of reference compounds and deuterium- labelled compounds for GC-MS work as well as labels for time-resolved immunoassay and radioimmunoassay. The work involves synthesis of antigens for production of polyclonal and monclonal antibodies. This laboratory in close collaboration with the Department of Chemistry at the same university since 15 years has provided numerous deuterated and nondeuterated standards of lignans and isoflavonoids to research groups in many countries, mainly to research groups in USA. This we will continue if we can get continuation of the grant support.
大豆已被发现含有异黄酮和木脂素。这些

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CARL H ADLERCREUTZ其他文献

CARL H ADLERCREUTZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CARL H ADLERCREUTZ', 18)}}的其他基金

METABOLISM OF SOYBEAN ISOFLAVONOIDS AND LIGNANS IN MAN
大豆异黄酮和木脂素在人体中的代谢
  • 批准号:
    3200687
  • 财政年份:
    1992
  • 资助金额:
    $ 13.91万
  • 项目类别:
METABOLISM OF SOYBEAN ISOFLAVONOIDS AND LIGNANS IN MAN
大豆异黄酮和木脂素在人体中的代谢
  • 批准号:
    3200688
  • 财政年份:
    1992
  • 资助金额:
    $ 13.91万
  • 项目类别:
METABOLISM OF SOYBEAN ISOFLAVONOIDS AND LIGNANS IN MAN
大豆异黄酮和木脂素在人体中的代谢
  • 批准号:
    2097207
  • 财政年份:
    1992
  • 资助金额:
    $ 13.91万
  • 项目类别:
METABOLISM OF SOYBEAN ISOFLAVONOIDS AND LIGNANS
大豆异黄酮和木脂素的代谢
  • 批准号:
    2097206
  • 财政年份:
    1992
  • 资助金额:
    $ 13.91万
  • 项目类别:
METABOLISM OF SOYBEAN ISOFLAVONOIDS AND LIGNANS IN MAN
大豆异黄酮和木脂素在人体中的代谢
  • 批准号:
    2633830
  • 财政年份:
    1992
  • 资助金额:
    $ 13.91万
  • 项目类别:

相似海外基金

Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9981001
  • 财政年份:
    2017
  • 资助金额:
    $ 13.91万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9751102
  • 财政年份:
    2017
  • 资助金额:
    $ 13.91万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9397073
  • 财政年份:
    2017
  • 资助金额:
    $ 13.91万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    10223410
  • 财政年份:
    2017
  • 资助金额:
    $ 13.91万
  • 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
  • 批准号:
    7951676
  • 财政年份:
    2008
  • 资助金额:
    $ 13.91万
  • 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
  • 批准号:
    7606036
  • 财政年份:
    2006
  • 资助金额:
    $ 13.91万
  • 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    7375053
  • 财政年份:
    2005
  • 资助金额:
    $ 13.91万
  • 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    7201220
  • 财政年份:
    2004
  • 资助金额:
    $ 13.91万
  • 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    6980810
  • 财政年份:
    2003
  • 资助金额:
    $ 13.91万
  • 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
  • 批准号:
    6419444
  • 财政年份:
    2000
  • 资助金额:
    $ 13.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了